---
title: "Amaze Holdings director Aaron Day resigns from board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296209974.md"
description: "Amaze Holdings director Aaron Day resigned from the board on August 14, 2026, effective immediately. The departure was not related to any disputes regarding the company's operations, policies, or practices."
datetime: "2026-08-18T10:03:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296209974.md)
  - [en](https://longbridge.com/en/news/296209974.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296209974.md)
generator: "portal-rs"
---

# Amaze Holdings director Aaron Day resigns from board

-   Amaze Holdings director Aaron Day resigned from the board on Aug. 14, 2026, effective immediately. \* The departure was not tied to any dispute over the company’s operations, policies, or practices. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amaze Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038826), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [AMZE.US](https://longbridge.com/en/quote/AMZE.US.md)

## Related News & Research

- [Amaze Holdings Announces Cost Reduction Plan Targeting Approximately 40% Reduction in Operating Expenses | AMZE Stock News](https://longbridge.com/en/news/297053162.md)
- [AMZE: Q2 2026 revenue fell 29% YoY, net loss narrowed, but going concern risks remain high](https://longbridge.com/en/news/295978827.md)
- [IBA publishes H1 2026 results presentation](https://longbridge.com/en/news/297180350.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Cumberland Pharma says ifetroban Phase 2 DMD extension data not ready, pulls August 2026 timing](https://longbridge.com/en/news/297369585.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**